Loading...
Loading...
Bristol-Myers
Squibb Company
BMY today announced the appointment of Francis
Cuss, MB BChir, FRCP, 58, as executive vice president and chief
scientific officer, effective July 1 after Elliott
Sigal, M.D., Ph.D., 61, retires. Dr. Sigal has served as the
company's chief scientific officer since 2004 and on the company's Board
of Directors since 2011. He will retire from both positions effective
June 30, 2013. Drs. Sigal and Cuss will continue to work together until
that time.
“Francis is a strong and collaborative leader with broad experience in
both discovery and development,” said Lamberto
Andreotti, chief executive officer, Bristol-Myers Squibb. “He has
been a key member of our productive
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in